ChemoCentryx, Inc. 4
4 · ChemoCentryx, Inc. · Filed May 3, 2017
Insider Transaction Report
Form 4
LUCAS ROGER C
Director
Transactions
- Sale
Common Stock
2017-05-01$7.31/sh−4,000$29,228→ 62,822 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $7.11 to $7.40 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.